Tweed service to focus on Charlotte, not Philly
American Airlines will cease its longstanding American Eagle daily service between Tweed New Haven Regional Airport and Philadelphia, but expand to twice daily its service...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
American Airlines will cease its longstanding American Eagle daily service between Tweed New Haven Regional Airport and Philadelphia, but expand to twice daily its service...
Trevi Therapeutics has completed the pre-specified sample size re-estimation analysis for the ongoing PRISM Phase 2b/3 trial of Haduvio for severe pruritus in patients with prurigo...
NanoViricides has completed an underwritten public offering with gross proceeds of $11.5 million. The company is developing antiviral therapies based on a novel nanomedicines platform....
New Haven’s Board of Alders has thrown its unanimous support behind a $100 million, 10-story bioscience tower in the heart of the city’s downtown. Meeting virtually...
Massachusetts General Hospital will use a New Haven biotechnology company’s experimental agitation drug to treat symptoms of “ICU delirium” in critically ill patients hospitalized with...
Healing broken bones could get easier with a device that provides both a scaffold for the bone to grow on and electrical stimulation to urge...
Twenty of the world’s largest pharmaceutical companies on Thursday announced the creation of a $1 billion fund to buoy financially strapped biotech start-ups that are...
Pfizer and BioNTech report that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being developed to...
Kleo Pharmaceuticals, the five-year-old New Haven biotech based in Science Park, has secured a $5 million grant from the Bill & Melinda Gates Foundation for its...
Cybrexa Therapeutics has successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II...